116 related articles for article (PubMed ID: 32592842)
1. Diabetes and COVID-19: IDF perspective in the Western Pacific region.
Hwang Y; Khasag A; Jia W; Jenkins A; Huang CN; Yabe D; Kim DM; Kadowaki T; Lee MK
Diabetes Res Clin Pract; 2020 Aug; 166():108278. PubMed ID: 32592842
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and diabetes from IDF MENA region.
Belkhadir J
Diabetes Res Clin Pract; 2020 Aug; 166():108277. PubMed ID: 32592837
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and COVID-19: Global and regional perspectives.
Jeong IK; Yoon KH; Lee MK
Diabetes Res Clin Pract; 2020 Aug; 166():108303. PubMed ID: 32623038
[TBL] [Abstract][Full Text] [Related]
4. Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic.
Sacks LJ; Pham CT; Fleming N; Neoh SL; Ekinci EI
Diabetes Res Clin Pract; 2020 Aug; 166():108296. PubMed ID: 32623041
[TBL] [Abstract][Full Text] [Related]
5. The diabetic lung: An easy target for SARS-CoV-2?
Caruso I; Giorgino F
Diabetes Metab Res Rev; 2020 Nov; 36(8):e3346. PubMed ID: 32426928
[No Abstract] [Full Text] [Related]
6. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T
Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119
[No Abstract] [Full Text] [Related]
7. COVID-19 impact on people with diabetes in South and Central America (SACA region).
Barone MTU; Villarroel D; de Luca PV; Harnik SB; Lima BLS; Wieselberg RJP; Giampaoli V
Diabetes Res Clin Pract; 2020 Aug; 166():108301. PubMed ID: 32623036
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series.
Chan KH; Thimmareddygari D; Ramahi A; Atallah L; Baranetsky NG; Slim J
Diabetes Res Clin Pract; 2020 Aug; 166():108279. PubMed ID: 32592843
[TBL] [Abstract][Full Text] [Related]
9. Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis.
Parveen R; Sehar N; Bajpai R; Agarwal NB
Diabetes Res Clin Pract; 2020 Aug; 166():108295. PubMed ID: 32623032
[TBL] [Abstract][Full Text] [Related]
10. Diabetes care during COVID-19 lockdown at a tertiary care centre in India.
Joshi R; Atal S; Fatima Z; Balakrishnan S; Sharma S; Joshi A
Diabetes Res Clin Pract; 2020 Aug; 166():108316. PubMed ID: 32673697
[TBL] [Abstract][Full Text] [Related]
11. The impact of COVID-19 on people with diabetes in Brazil.
Barone MTU; Harnik SB; de Luca PV; Lima BLS; Wieselberg RJP; Ngongo B; Pedrosa HC; Pimazoni-Netto A; Franco DR; Marinho de Souza MF; Malta DC; Giampaoli V
Diabetes Res Clin Pract; 2020 Aug; 166():108304. PubMed ID: 32623040
[TBL] [Abstract][Full Text] [Related]
12. The Coronavirus 2019 Pandemic and Diabetes: An International Perspective.
Klonoff DC
J Diabetes Sci Technol; 2020 Jul; 14(4):703-704. PubMed ID: 32517506
[No Abstract] [Full Text] [Related]
13. Diabetes and COVID-19: A systematic review on the current evidences.
Abdi A; Jalilian M; Sarbarzeh PA; Vlaisavljevic Z
Diabetes Res Clin Pract; 2020 Aug; 166():108347. PubMed ID: 32711003
[TBL] [Abstract][Full Text] [Related]
14. Diabetes Management during the COVID-19 Pandemic: An Iranian Expert Opinion Statement.
Malek M; Hosseinpanah F; Aghaei Meybodi HR; Jahed SA; Hadaegh F; Sharghi S; Esteghamati A; Khamseh ME
Arch Iran Med; 2020 Aug; 23(8):564-567. PubMed ID: 32894970
[TBL] [Abstract][Full Text] [Related]
15. The COVID-19 Pandemic from an Ophthalmologist's Perspective.
Bacherini D; Biagini I; Lenzetti C; Virgili G; Rizzo S; Giansanti F
Trends Mol Med; 2020 Jun; 26(6):529-531. PubMed ID: 32470381
[TBL] [Abstract][Full Text] [Related]
16. Association Between Diabetes and COVID-19: A Retrospective Observational Study With a Large Sample of 1,880 Cases in Leishenshan Hospital, Wuhan.
Liu Z; Li J; Huang J; Guo L; Gao R; Luo K; Zeng G; Zhang T; Yi M; Huang Y; Chen J; Yang Y; Wu X
Front Endocrinol (Lausanne); 2020; 11():478. PubMed ID: 32760350
[No Abstract] [Full Text] [Related]
17. Prevalence and impact of diabetes among people infected with SARS-CoV-2.
Fadini GP; Morieri ML; Longato E; Avogaro A
J Endocrinol Invest; 2020 Jun; 43(6):867-869. PubMed ID: 32222956
[No Abstract] [Full Text] [Related]
18. Coronavirus: COVID-19 Transmission in Pacific Small Island Developing States.
Leal Filho W; Lütz JM; Sattler DN; Nunn PD
Int J Environ Res Public Health; 2020 Jul; 17(15):. PubMed ID: 32731327
[TBL] [Abstract][Full Text] [Related]
19. Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review.
Wicaksana AL; Hertanti NS; Ferdiana A; Pramono RB
Diabetes Metab Syndr; 2020; 14(5):1109-1120. PubMed ID: 32659694
[TBL] [Abstract][Full Text] [Related]
20. Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study.
Li Y; Han X; Alwalid O; Cui Y; Cao Y; Liu J; Gu J; Wang L; Fan Y; Shi H
Diabetes Res Clin Pract; 2020 Aug; 166():108299. PubMed ID: 32623030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
